AbbVie Inc. has fully acquired Gilgamesh Pharmaceuticals' lead investigational candidate, bretisilocin, which represents a major expansion of AbbVie's neuroscience pipeline.
Dr Reddy's Laboratories Ltd reports that it has obtained an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its formulations manufacturing plant (FTO 11) in Srikakulam, Andhra Pradesh...
Boston Scientific Corporation announced a definitive agreement to acquire Nalu Medical, Inc., a privately held medtech company that develops minimally invasive solutions for chronic pain management.
Merck's Phase 3 HIV trial highlights expertise in antiviral science, authority in clinical research, and advancing effective treatments showing minimal metabolic impact and reaffirming Merck's commitment to evidence-based HIV care
Fortis Hospital, Mulund, has inaugurated its Fortis Cancer Institute and Institute of GastroSciences, marking a significant milestone in its mission to deliver comprehensive, patient-first healthcare.
The Food and Drug Administration (FDA) in Haryana has intensified its efforts to counter the issue of adulteration of pharmaceutical ingredients, and recently issued a "Most Urgent" alert to increase scrutiny of propylene glycol (PG), which is...
AstraZeneca Pharma India Limited will be introducing Lokelma (Sodium Zirconium Cyclosilicate powder) for oral suspension in November 2025.
Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), among the 10 leading fixed-dosage injectable manufacturers in the world, has inaugurated its state-of-the-art Venus Global Fulfillment Center (VGFC).
The distribution was completely disregarded in this country. However, the time has come since distribution does not just imply taking the product and delivering to people in different locations.
Pfizer Inc. will be presenting the latest developments of their infectious disease portfolio at IDWeek 2025 from October 19-22, 2025.
.jpg)
.jpg)
, CDSCO.jpg)